Cargando…

A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies

BACKGROUND: Predicting lung adenocarcinoma (LUAD) risk is crucial in determining further treatment strategies. Molecular biomarkers may improve risk stratification for LUAD. METHODS: We analyzed the gene expression profiles of LUAD patients from The Cancer Genome Atlas (TCGA) and Gene Expression Omn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yin, Ge, Di, Gu, Jie, Xu, Fengkai, Zhu, Qiaoliang, Lu, Chunlai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729062/ https://www.ncbi.nlm.nih.gov/pubmed/31488089 http://dx.doi.org/10.1186/s12885-019-6101-7

Ejemplares similares

Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data
por: Li, Yin, et al.
Publicado: (2018)

High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma
por: Zhu, Qiaoliang, et al.
Publicado: (2020)

Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study
por: Zhao, Guangyin, et al.
Publicado: (2023)

Development of a ferroptosis-based model to predict prognosis, tumor microenvironment, and drug response for lung adenocarcinoma with weighted genes co-expression network analysis
por: Cheng, Tao, et al.
Publicado: (2022)

Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway
por: Xu, Fengkai, et al.
Publicado: (2019)

An individual nomogram can reliably predict tumor spread through air spaces in non-small-cell lung cancer
por: Wang, Shuai, et al.
Publicado: (2022)

Tumor size as a predictor for prognosis of patients with surgical IIIA-N2 non-small cell lung cancer after surgery
por: Zhang, Kunpeng, et al.
Publicado: (2021)

TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma
por: Xu, Fengkai, et al.
Publicado: (2019)

KLF11 regulates lung adenocarcinoma ferroptosis and chemosensitivity by suppressing GPX4
por: Zhao, Guangyin, et al.
Publicado: (2023)

Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma
por: Xu, Fengkai, et al.
Publicado: (2020)

Large Cell Neuroendocrine Carcinoma Shares Similarity with Small Cell Carcinoma on the Basis of Clinical and Pathological Features()()
por: Xu, Fengkai, et al.
Publicado: (2019)

BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma
por: Ma, Teng, et al.
Publicado: (2022)

Up-regulation Of EIF3e Is Associated with The Progression of Esophageal Squamous Cell Carcinoma and Poor Prognosis in Patients
por: Xu, Fengkai, et al.
Publicado: (2018)

Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma
por: Li, Yin, et al.
Publicado: (2021)

Comprehensive Genome-Scale Analysis of Esophageal Carcinoma With Esophageal Tissue-Resident Micro-Environment Discrepancy
por: Yang, Huiqin, et al.
Publicado: (2022)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

Identification and Validation of Anoikis-Related Signatures for Predicting Prognosis in Lung Adenocarcinoma with Machine Learning
por: Wang, Qilong, et al.
Publicado: (2023)

A Recurrence-Specific Gene-Based Prognosis Prediction Model for Lung Adenocarcinoma through Machine Learning Algorithm
por: Xu, Shaohua, et al.
Publicado: (2020)

Machine learning identifies characteristics molecules of cancer associated fibroblasts significantly correlated with the prognosis, immunotherapy response and immune microenvironment in lung adenocarcinoma
por: Wang, Qian, et al.
Publicado: (2022)

Identification of mitochondrial respiratory chain signature for predicting prognosis and immunotherapy response in stomach adenocarcinoma
por: Yang, Jing, et al.
Publicado: (2023)

Developing Prognosis Tools to Identify Learning Difficulties in Children Using Machine Learning Technologies
por: Loizou, Antonis, et al.
Publicado: (2010)

Cancer-associated fibroblasts are associated with poor prognosis in solid type of lung adenocarcinoma in a machine learning analysis
por: Min, Kyueng-Whan, et al.
Publicado: (2021)

Machine learning developed a programmed cell death signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma
por: Ding, Dongxiao, et al.
Publicado: (2023)

Multiomics and machine learning in lung cancer prognosis
por: Gao, Yanan, et al.
Publicado: (2020)

Machine-learning and combined analysis of single-cell and bulk-RNA sequencing identified a DC gene signature to predict prognosis and immunotherapy response for patients with lung adenocarcinoma
por: Zhang, Liangyu, et al.
Publicado: (2023)

A Pathway-Based Strategy to Identify Biomarkers for Lung Cancer Diagnosis and Prognosis
por: Sheng, Mengying, et al.
Publicado: (2019)

Machine learning strategy for identifying altered gut microbiomes for diagnostic screening in myasthenia gravis
por: Chang, Che-Cheng, et al.
Publicado: (2023)

Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma
por: Yang, Weichang, et al.
Publicado: (2023)

Machine Learning for Lung Cancer Diagnosis, Treatment, and Prognosis
por: Li, Yawei, et al.
Publicado: (2022)

The Application and Comparison of Machine Learning Models for the Prediction of Breast Cancer Prognosis: Retrospective Cohort Study
por: Xiao, Jialong, et al.
Publicado: (2022)

Identifying Effective Biomarkers for Accurate Pancreatic Cancer Prognosis Using Statistical Machine Learning
por: Abu-Khudir, Rasha, et al.
Publicado: (2023)

A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma
por: Zhang, Yi, et al.
Publicado: (2023)

USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma
por: Zhao, Guang-Yin, et al.
Publicado: (2014)

Identification of a Sixteen-gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning Method
por: Ma, Baoshan, et al.
Publicado: (2020)

Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway
por: Xu, Fengkai, et al.
Publicado: (2016)

Identifying Common Genes Related to Platelet and Immunity for Lung Adenocarcinoma Prognosis Prediction
por: Zhou, Chengmao, et al.
Publicado: (2020)

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
por: Chen, Yingji, et al.
Publicado: (2021)

Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies
por: Xue, Liang, et al.
Publicado: (2020)

Transcriptomic analysis identifies CYP27A1 as a diagnostic marker for the prognosis and immunity in lung adenocarcinoma
por: Yin, Yi, et al.
Publicado: (2023)

Significance of Spliceosome-Related Genes in the Prediction of Prognosis and Treatment Strategies for Lung Adenocarcinoma
por: Yang, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gqd51ktr9vvdrcr041n44f3dv5